Cargando…
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
Background: Establishment of heterotopic patient-derived xenografts of primary and relapsed non-muscular invasive bladder cancer (NMIBC) to explore the biological property of PD-L1 signaling that may impact bladder tumor growth in humanized animals. Methods: Tumor cells of luminal, basal, and p53 su...
Autores principales: | Blinova, Ekaterina, Roshchin, Dmitry, Kogan, Evgenya, Samishina, Elena, Demura, Tatiana, Deryabina, Olga, Suslova, Irina, Blinov, Dmitry, Zhdanov, Pavel, Osmanov, Usif, Nelipa, Mikhail, Kaprin, Andrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628037/ https://www.ncbi.nlm.nih.gov/pubmed/31159302 http://dx.doi.org/10.3390/cells8060526 |
Ejemplares similares
-
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
por: Blinova, Ekaterina V., et al.
Publicado: (2018) -
Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression
por: Samishina, Elena A., et al.
Publicado: (2019) -
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma
por: Blinova, Ekaterina, et al.
Publicado: (2021) -
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
por: Blinova, Ekaterina, et al.
Publicado: (2020) -
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
por: Blinova, Ekaterina, et al.
Publicado: (2020)